Status:
UNKNOWN
Study Pilot - Hybrid EEG/fMRI Neurofeedback in Depressed Patients
Lead Sponsor:
Rennes University Hospital
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Cognitive impairment is a common residual symptom after a depressive episode and expose patients to a risk of relapsing or therapeutic resistance. Neurofeedback (using ElectroEncephaloGraphy - EEG or...
Eligibility Criteria
Inclusion
- Aged 18 to 65 years old
- Signature of an informed consent after being given clear and loyal oral and written information
Exclusion
- Related to the volunteer
- Prior experience of a neurofeedback task
- Related to the MRI
- Implanted cardiac pacemaker of defibrillator
- Brain aneurysm clip
- Cochlear implant
- Ocular on encephalic metallic foreign body
- Endoprothesis implanted for less than 4 weeks and ostheosynthesis device implanted for less than 6 weeks.
- Claustrophobia
- Other criteria
- Unstable hemodynamic status
- Acute respiratory failure
- Alteration of general state or continuous monitoring requirement
- Other psychiatric condition (DSM-5) such as schizophrenia, substance abuse…
- Neurological condition or diagnosis of dementia in medical history
- Undergoing treatment by benzodiazepines or anticonvulsants prescribed less than a month prior to inclusion
- Undergoing treatment influencing the blood flow prescribed less than three weeks prior to inclusion
- Protected person (adults legally protected (under judicial protection, guardianship or supervision), person deprived of their liberty, pregnant woman, lactating woman and minor)
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04450186
Start Date
August 10 2020
End Date
December 1 2021
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU
Rennes, France